Viewing nowJanuglo 50 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 56.69mg
Tablet · Prescription medication
Samchundang Pharm Co., Ltd.

MFDS item code 202301961 · Approved 2023.06.27 · Insurance code 651206060
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help improve blood sugar control in patients with type 2 diabetes. Initially, it can be given alone along with diet and exercise therapy. If there is no prior experience of diabetes treatment and blood sugar control is difficult with monotherapy, it can be taken in conjunction with metformin. Additionally, it is added for combination therapy when blood sugar control is difficult with monotherapy of sulfonylureas, metformin, thiazolidinediones, or insulin. When multiple drugs are used in combination, this medication helps enhance blood sugar control. Therefore, it is effectively used to improve blood sugar control in type 2 diabetes.
The recommended dose of this medication, whether used as monotherapy or in combination therapy, is 100 mg once daily. The maximum daily dose is 100 mg. This medication may be taken with or without food. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is necessary, assessment of renal function before treatment and periodically thereafter is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. For patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. For patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medication may be administered without regard to the timing of dialysis.
This medication may cause severe allergic reactions after administration; therefore, if symptoms such as skin rash or difficulty breathing occur, it should be discontinued immediately and a physician should be consulted. Furthermore, during the use of this medication, serious pancreatitis may develop, so if symptoms such as abdominal pain or vomiting occur, it should be reported to medical personnel immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should also be avoided in cases of hypersensitivity to this medication or its ingredients. Patients with impaired renal function may have difficulty excreting this medication; thus, the dosage should be carefully adjusted. This medication can cause hypoglycemia when used alone or in combination with other diabetes medications, so caution must be taken to monitor for hypoglycemic symptoms when taken with insulin or sulfonylureas. Severe joint pain may occur during medication use; therefore, if such symptoms develop, a physician should be consulted to determine whether to discontinue the medication. A rare skin disease called bullous pemphigoid has been reported; if blisters or erosions develop on the skin, a physician should be notified immediately. It is not recommended for use in pregnant or nursing women, and safety in children under 18 years of age has not been established, so use should be approached with caution. Elderly patients may experience reduced renal function; therefore, dosage adjustment and renal function tests are necessary. In cases of overdose, general supportive treatment is required; this medication can be partially removed by hemodialysis, so patients should receive treatment according to medical personnel's instructions. Lastly, interactions with other medications are generally rare, but when taken with certain medications, it is important to inform medical personnel and adjust medications if needed.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it is recommended to store it at room temperature between 1°C and 30°C. By storing it this way, the effectiveness of the medication can be maintained for a long time.
Bright yellow-orange circular film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 56.69mg
Tablet · Prescription medication
Samchundang Pharm Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.